Date: 2014-09-10
Type of information: Company acquisition
Acquired company: Diametra (Italy)
Acquiring company: Immunodiagnostic Systems (UK)
Amount: undisclosed
Terms: * On September 10, 2014, Immunodiagnostic Systems Holdings PLC announced that it has acquired Diametra, an Italian company specialised in the development and commercialisation of manual immunoenzymatic assays. The acquisition is in line with the Group\'s strategy of building its presence as a leading solution provider for speciality testing. In particular, the acquisition augments the Group\'s endocrinology pipeline.
Details: Diametra is based in Spello, Umbria and employs approximately 25 staff. In the year-ended 31 December 2013, Diametra generated revenues of €3.3m and an EBIT of €0.3m. For the past nine months, IDS and Diametra have been collaborating on the conversion of one of Diametra\'s manual assays onto the fully automated IDS-iSYS instrument. Following the acquisition, it is IDS\'s intention to convert a number of Diametra\'s manual assays in the area of steroid hormones onto the IDS-iSYS automated instrument. In addition, the acquisition of Diametra provides IDS with additional development and manufacturing capabilities.
Related: diagnostic
